Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M. (Marco) de Bruyn

Publicaties

MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage

Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer

Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

B cells critical for outcome in high grade serous ovarian carcinoma

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Correction to: Prediction of recurrence risk in endometrial cancer with multimodal deep learning (Nature Medicine, (2024), 10.1038/s41591-024-02993-w)

Genomic instability as a driver and suppressor of anti-tumor immunity

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

Pers/media